Additionally, Hassan et al. [23], comparing the expression of caspase-3 in healthy subjects, in patients with benign ovarian tumor, and in women with ovarian cancer, showed a lower expression of the enzyme in the group of patients with benign and malignant tumor compared to healthy subjects. Here, CASP3 is linked to ovarian benign neoplasm.